Toronto, Ontario–(Newsfile Corp. – November 18, 2020) – Psyched Wellness Ltd. (CSE: PSYC) (OTC Pink: DCNPF) (formerly Duncan Park Holdings Corporation) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to inform investors that since commencing trading on the CSE on October 22, 2020, certain management and board members have purchased common shares in the company on the open market.
Jeffrey Stevens, CEO – purchased 250,000 Common Shares at an average cost of $0.1216
Terry Booth, Director – purchased 262,500 Common Shares at an average cost of $0.13
Michael Nederhoff, Chairman – purchased 100,000 Common Shares at an average cost of $0.11
The Company has also issued 500,000 options at $0.145 to Professor David Nutt for his increased capacity as a member of the board of directors.
“I am proud to share this news, I believe it demonstrates to our shareholders that we as a team, are all fully committed to growing Psyched Wellness,” said Jeff Stevens, CEO of the Company. “I am not aware of many other companies where the management and board purchased shares in the open market within the first month of trading.”
For further information, please contact:
Sign up for MORE news updates !
This article is written and published by The Cannabis Stock
Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies
The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.